Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3197 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3197, RRID:AB_1903955
- Product name
- EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Rabbit
- Storage
- -20°C
Submitted references Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion.
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.
Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
Rimkunas VM, Crosby KE, Li D, Hu Y, Kelly ME, Gu TL, Mack JS, Silver MR, Zhou X, Haack H
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Aug 15;18(16):4449-57
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Aug 15;18(16):4449-57
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.
Brevet M, Arcila M, Ladanyi M
The Journal of molecular diagnostics : JMD 2010 Mar;12(2):169-76
The Journal of molecular diagnostics : JMD 2010 Mar;12(2):169-76
Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.
Kawahara A, Yamamoto C, Nakashima K, Azuma K, Hattori S, Kashihara M, Aizawa H, Basaki Y, Kuwano M, Kage M, Mitsudomi T, Ono M
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jun 15;16(12):3163-70
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jun 15;16(12):3163-70
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Simonetti S, Molina MA, Queralt C, de Aguirre I, Mayo C, Bertran-Alamillo J, Sanchez JJ, Gonzalez-Larriba JL, Jimenez U, Isla D, Moran T, Viteri S, Camps C, Garcia-Campelo R, Massuti B, Benlloch S, Ramon y Cajal S, Taron M, Rosell R
Journal of translational medicine 2010 Dec 18;8:135
Journal of translational medicine 2010 Dec 18;8:135
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
Yu J, Kane S, Wu J, Benedettini E, Li D, Reeves C, Innocenti G, Wetzel R, Crosby K, Becker A, Ferrante M, Cheung WC, Hong X, Chirieac LR, Sholl LM, Haack H, Smith BL, Polakiewicz RD, Tan Y, Gu TL, Loda M, Zhou X, Comb MJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 May 1;15(9):3023-8
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 May 1;15(9):3023-8
No comments: Submit comment
No validations: Submit validation data